>ABOUT TAKEDA >Our Management

Our Management

( As of October 1, 2014 )

Board members

Representative Director
Chairman of the Board & CEO

Yasuchika Hasegawa

Representative Director President & COO

Christophe Weber

Senior Managing Director
Senior Vice President,
Corporate Strategy Officer, Corporate Strategy Department
President, Takeda Pharmaceuticals International, Inc. (not continuous presence)

Shinji Honda

Managing Director
Special Missions

Yasuhiko Yamanaka

Director
Chief Medical & Scientific Officer
Executive Vice President of Takeda Pharmaceuticals International, Inc.

Tadataka Yamada, M.D.

Director
Senior Vice President, Pharmaceutical Marketing Division

Masato Iwasaki, Ph.D.

Director,
Senior Vice President,
Chief Financial Officer

Francois Roger

Outside Director
Honorary Advisor, JFE Holdings, Inc.

Fumio Sudo

Outside Director
Chairman of the Board,
Mitsubishi Corporation

Yorihiko Kojima

Outside Director
Councilor,
Komatsu Ltd.

Masahiro Sakane

Corporate Auditors

Corporate Auditor

Naohisa Takeda

Corporate Auditor

Teruo Sakurada

Corporate Auditor

Tsuguoki Fujinuma

Corporate Auditor

Shiro Kuniya

Corporate Officers

Haruhiko Hirate

Corporate Communications & Public Affairs Officer,
Senior Vice President,
Corporate Communications Department

Nancy Joseph-Ridge, M.D.

General Manager
Pharmaceutical Development Division

Trevor Smith

President, EUCAN Business Unit

Tadao Hirouchi

Vice President, Pharmaceutical Marketing Division

Douglas Cole

President, US Business Unit

David Osborne

Global Human Resources Officer

Tetsuyuki Maruyama, Ph.D.

General Manager, Pharmaceutical Research Division

Yoshihiro Nakagawa

Global General Counsel

Christophe Bianchi

President, Global Oncology Business Unit

Rajeev Venkayya

President, Global Vaccine Business Unit

Giles Platford

President, Emerging Markets Business Unit

Thomas Wozniewski

Global Manufacturing and Supply Officer

Gerard Greco

Global Quality Officer

Mwana Lugogo

Global Compliance Officer